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Abstract Autosomal, dominantly inherited, non-chro­
maffin paragangliomas are tumors of the head and neck 
region occurring with a frequency of 1:30 000. Genomic 
imprinting probably influences the expression of the dis­
order, because tumor development is limited to individu­
als who have inherited the trait from their father. By link­
age analysis and haplotyping of a single large family in 
which the pattern of inheritance is consistent with ge­
nomic imprinting, we have mapped the gene to a 5 cM re­
gion of chromosome 1 lq 13.1 between D11S956 and 
PYGM. A maximum lod score of 7.62 at © = 0.0 was ob­
tained for D11S480. This interval does not overlap with a 
recently assigned locus for glomus tumors in other fami­
lies; 1 Iq22.3-q23.3. Furthermore, analysis of a second 
family showing the imprinting phenomenon resulted in 
the exclusion of the 5 cM area as the location of the dis­
ease gene, whereas an indication for linkage was obtained 
(Z = +2.65) with markers from the distal locus. These ob­
servations argue for the presence of two distinct imprinted 
genes for glomus tumors on 1 lq. A model for tumor initi­
ation and progression is presented based on all available 
information.
1:30000. Although a malignant transformation of these 
tumors is rare, surgical intervention is required whenever 
essential life functions become endangered by the contin­
uous enlargement of a tumor. The predisposition to tumor 
development is inherited as an autosomal dominant trait. 
Interestingly, all familial patients appear to have inherited 
the trait from their father, whereas children from obligate 
female carriers do not develop tumors. This has been at­
tributed to genomic imprinting (van der Mey et al. 1989). 
Independent linkage studies in single large families have 
assigned the gene to chromosome llq. Surprisingly, 
however, these studies revealed close linkage with mark­
ers from two different regions of llq , i.e., Ilq22-q23 
(Heutink et al. 1992) and 11 q l3 (Mariman et al. 1993). 
This has raised the possibility that the disorder is geneti­
cally heterogeneous with two different genes on l lq  being 
able to act as predisposing factors for glomus tumors. Re­
cently, the distal locus has been more accurately mapped 
to Ilq22.3-q23.3 between STMY and CD3D (Heutink et 
al. 1994). We report the fine mapping of the proximal 
gene locus (Mariman et al. 1993) and show that the two 
mapping intervals do not overlap.
Introduction
Non-chromaffin paragangliomas, also referred to as glo­
mus tumors or chemodectomas, are slow-growing tumors 
usually located at the head and neck region of the body at 
the crossing of parasympathetic nerves and large vessels. 
They occur among Caucasians with a frequency of about
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Materials and methods
Ascertainment of families and DNA isolation
The families studied here have been described before: Family 1 
(van Baars et al. 1982; Mariman et al, 1993), Family 2  (Bleker and 
Wereldsma 1986). The patients were diagnosed by standard clini­
cal examinations and, if necessary as in the case of offspring of fe­
male carriers, by whole body magnetic resonance imaging (MRI). 
During the past 12 years, several new cases have been included in 
Family 1. Family 2 has been extended by our group since 1986 
with an extra branch comprising two affected sisters and iheir fa­
ther (individual III. 1 in Fig. 3) who, by MRI examination, was 
shown to be clinically unaffected, probably because of genomic im­
printing. Cytogenetic analysis of blood cells from patients of Fam­
ily 1, including fluorescence in situ hybridization with various cos- 
mid clones, revealed no gross rearrangements of l lq  or any other 
chromosome. Venous blood was sampled from relevant family 
members and genomic DNA was isolated as described by Miller et 
al. (1988).
Fig. 1 Location of highly 
polymorphic markers in the 
pericentromeric region of 
chromosome 11. The relative 
order and genetic distances are 
based on data obtained from 
the Genome Data Base. The 
position of two markers, CNTF 
and D11S480, with respect to 
D11S956 is less certain, be­
cause CNTF was mapped by in 
situ hybridization (Giovannini 
et al. 1993), whereas D11S480 
has only been genetically lo­
calized with respect to PYGM 
(Fujimori et al. 1992). The 
position of the glomus tumor 
gene, as concluded from the 
present study, is indicated
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Analysis of genetic markers
Highly polymorphic markers were selected from the pericen­
tromeric region of chromosome 11. Their order and estimated ge­
netic distances are shown in Fig. 1. Markers were also selected 
from the region between STMY and CD 3D (Table 1), to which a 
gene for glomus tumors has been assigned by others (Heutink et 
al. 1994). All markers (Table 1) were analyzed by polymerase 
chain reaction amplification of genomic DNA under the condi­
tions described by Weber and May (1989) and by using locus- 
specific primers as given in the Genome Data Base, in the reac­
tion mixture, *2P-dCTP was included to label the amplification 
products. Amplification was performed in a 96-well thermal cy­
cler (MJ Research, Watertown) with Super Taq DNA polymerase 
(HT Biotechnology, Cambridge). Subsequently, the DNA frag­
ments were loaded on standard 6.6%  denaturing polyacrylamide 
gels and separated by electrophoresis for 3h at 60 W, The gels 
were then dried and exposed to Kodak X-ray film to visualize the 
individual allelic bands.
Linkage analysis
Lod scores were calculated with the MLiNK and LINKMAP options 
of the program LINKAGE version 5.10 (Lathrop et al. 1985). A fre­
quency of 1:50000 was assumed for the glomus tumor gene. For 
children from male carriers, five liability classes were defined to ac­
count for age-dependent tumor development (van Baars et al. 1982):
1.0 (>50 years of age), 0.9 (40-50 years), 0.6 (30-40 years), 0.3 
(20-30 years), and 0.1 (<20 years). Multipoint linkage analysis of 
Family 2 (Fig. 3) was performed with D11S956 and PYGM, which 
are separated by 5cM (Litt et al. 1993), and with D11S897 and 
D11S490 at a distance of 14cM (C11M19, Cl 1M48 of GDB). Ge­
nomic imprinting was assumed for the second and third generation, 
and was incorporated into the linkage calculations by a separate lia­
bility class with a penetrance of 0 .0  for children of female gene car­
riers (Heutink et al. 1992). For most marker loci, linkage analyses 
were based on the reported allele frequencies, except for CNTF and 
D11S480. For these markers, allele frequencies were determined by 
the analysis of 50 unrelated persons from the Dutch population.
Fig. 2 Haplotype analysis of 
the three branches of Family 1: 
Pedigree A (A), Pedigree B 
(B) and Pedigree C (C). Ob­
ligate carriers from older gen­
erations, for whom no data re­
garding clinical status were 
available, are represented by 
open symbols. The markers 
that were used to construct 
haplotypes are shown. The 
haplotype, which co-segregates 
with the disorder, is indicated 
by hatched bars. For female 
A-V. 1 in Pedigree A (A), the 
two hatched bars correspond 
to the haplotypes segregating 
with the disorder in Pedigree A 
(A) and B/C (B, C), respec­
tively
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Results
Two-point linkage analysis in Family 1
Part of Family 1 has previously been studied by linkage 
analysis with markers distributed along chromosome llq  
(Mariman et al. 1993). An indication for linkage was ob­
tained in pedigree A between the disorder and markers
FGF3 (formerly INT2, llq  13.3) and DIIS527 ( l lq  13.5),
whereas recombination had been observed with the locus 
for TYR (Ilql4-q21). Furthermore, different FGF3 alle­
les were seen to co-segregate with the disorder in Pedi­
grees A and B, suggesting that the gene for glomus tu­
mors is located proximal to FGF3. To increase the infor- 
mativity of Family 1 , a considerable number of family
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Table 1 Results of two-point 
linkage analysis of Family 1 Locus Location Lod score (0)
0 .0 0 0.05 0 .1 0 0 .2 0 0.30 0.40
D11S569 l l p l 4 —  o o - 6.21 -3.45 -1.16 -0.28 - 0.01
BDNF l lp l 3 —  o o 0.49 1.17 1.31 0,94 0.42
D U S935 1 lp l3 —  o o 2.03 2.18 1.85 1.23 0.51
D11S905 1 lp 12 —  o o 4.19 4.21 3.42 2.21 0.87
D11S554 1 l p l 2- p l  1.2 —  o o 5,23 4,96 3.90 2.52 1.02
CNTF 11 q 12 5.23 4.69 4.12 2.94 1.76 0.69
D11S956 1 l q l 3 .1 —  o o 3.52 3.58 2 .8 8 1.74 0.48
D11S480 1 1 q 13.1 7.62 6.93 6.21 4.69 3.06 1.37
PYGM 1 lql3.1 —  o o 3.87 4.09 3.44 2.27 0.95
FGF3 11 q 13,3 —  OO 2.05 2.29 1.94 1.23 0.47
D11S527 1 Iq 13.5 —  o o 0,76 1.55 1.72 1.27 0.60
D11S927 1 lq 2 2 —  C O -3.12 ” 1.20 0.17 0.44 0.27
D11S897 llq23.1 —  o o -2.69 -1.84 0.42 0.61 0.36
APOC3 llq23-q ter —  o o -1.27 -0.26 0.36 0.39 0 .2 2
D 11S490 llq23.3 —  o o -1.44 -0.39 0.37 0.42 0 .2 0
Fig. 3 Pedigree of Family 2. 
The principles of genomic im­
printing seem to apply to this 
family as revealed by the unaf­
fected status, at the age of 65, 
of obligate carrier IIL1, who 
has inherited the genetic defect 
from his mother, No obligate 
carriers in the second genera­
tion have developed glomus tu­
mors
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members has been added (Fig. 2). Highly polymorphic 
markers were selected from the pericentromeric region of 
chromosome 11 (Fig. 1) and linkage analysis was per­
formed with a part of Family 1 comprising Pedigrees A 
(Fig.2A) and B (Fig.2B). As can be seen in Table 1, pos­
itive lod scores were obtained with most of the markers. 
For CNTF and D11S480, maximum lod scores of 5.23 
and 7.62 were obtained at © = 0.0. For these two markers, 
the same allele was seen to co-segregate with the disorder 
throughout the family, whereas for all other tested mark­
ers, different alleles appeared to co-segregate in Pedigrees 
A and B, respectively, suggesting recombination(s) be­
tween these markers and the disease gene. In addition, 
four markers from the distal region, defined by Heutink et 
al. (1994) as the location of a gene for glomus tumors, 
were used for two-point linkage analysis (Table 1). Nega­
tive lod scores were obtained with all of these markers 
(Table 1), thus substantiating our previous conclusion 
that, in Family 1, the location of the gene is more proxi­
mal.
Haplotype analysis of Family 1
Haplotypes were constructed from the alleles of six 
marker loci used for linkage analysis. In pedigree A (Fig. 
2A), a common haplotype segregates with the disorder in 
the offspring of individual A-IV.3. When the affected fe­
male A-V.l is included in the analysis, the common hap­
lotype is limited to the lower three markers. Therefore, the 
responsibe gene is located distal to D11S956. In pedigree 
B (Fig.2B), a common haplotype was constructed for the 
affected persons only, minimizing the number of recombi­
nation events (Thompson 1987). A comparison of this 
haplotype with that of female A-V.l (Fig.2A) shows that 
they have only that part defined by the upper four markers 
in common. From these data, we conclude that the gene 
for glomus tumors in Family 1 is located at 1 l q l 3.1 be­
tween D11S956 and PYGM within a region of 5 cM. 
Marker D11S480, which lies at a distance 4cM proximal 
from PYGM (Fujimori et al. 1992), showed no recombi­
nation with the disorder. Genotyping the available persons 
of Pedigree C (Fig.2C; C-VII.l and her parents) estab­
lished that the patient inherited the same haplotype as pa­
tients of Pedigree B; this does not allow further fine-map­
ping of the underlying gene.
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Fig. 4 Multipoint linkage 
analysis of Family 2. Linkage 
calculations were performed 
with markers D11S956 and 
PYGM flanking the glomus tu­
mor gene. Genomic imprinting 
was taken into account by 
defining a separate liability 
class with a 0 .0  penetrance for 
children from obligate female 
carriers. The dashed horizontal 
line corresponds to a multi­
point lodscore of Z = -2
D11S956 PYGM
<DL.o
o
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Evidence for genetic heterogeneity
Another family with inherited glomus tumors, Family 2 
(Fig. 3), was investigated similarly. The pattern of inheri­
tance in this family is consistent with genomic imprinting. 
Affected persons have received the predisposing gene 
from their father, whereas male III-1, who has inherited 
the genetic defect from his mother, shows no signs of the 
disorder at .the age of 65. Moreover, no signs of tumor de­
velopment were noticed by clinical examination or by 
MRI in the living obligate earners of the second genera­
tion, despite their longevity (>79 years). This suggests 
that the genetic defect was inherited from the great-grand­
mother 1.2. Multipoint linkage analysis was performed 
with the flanking markers D11S956 and PYGM. As can 
be seen in Fig, 4, the interval between D11S956 and 
PYGM is excluded as the location of the gene for glomus 
tumors in this family (Z < -2). The maximum multipoint lod 
score was Z = -3,47. When markers from the region 
Ilq22.3-q23.3 were used for linkage analysis, positive 
lod scores were obtained. Multipoint linkage analysis was 
performed with D11S897 and D11S490 to optimize the 
informativity and this yielded a maximum lod score of Z 
= +2.65 at D11S490. Together, these findings argue for 
the involvement of two separate genes, both located on 
chromosome llq , and both predisposing for the develop­
ment of glomus tumors.
Discussion
The present study strongly supports the existence of ge­
netic heterogeneity in the predisposition for glomus tumor 
development, with two genes being located on chromo­
some llq . The data reported here show that one of these 
genes is located close to the centromere at 1 l q l3* 1 , 
whereas the other gene has been mapped to llq22.3- 
q23.3 (Heutink et al. 1994). The pericentromeric region of 
chromosome 11 contains at least three genes coding for
factors, (neurotrophins) that are able to regulate in vitro 
the growth and differentiation of specific neurons; these 
factors include brain-derived neurotrophic factor (BDNF, 
1 ip 13), midkine (MDK, NEGF2, l lp ll .2 ) , and ciliary 
neurotrophic factor (CNTF, llq l2 ). They may also be 
able to influence the growth of paraganglionic cells, and 
their genes can be regarded as candidates for the present 
disorder. The gene for CNTF, for which no recombination 
was observed in Family 1, has been mapped to l lq  12 by 
in situ hybridization (Giovannini et al. 1993). However, 
regarding the restricted resolution of this procedure, band 
l lq  13.1 is not excluded as the location of the CNTF gene 
(Smith et aL 1993). Therefore, we have tested the coding 
region of this gene by single-strand conformation analysis 
for the presence of mutations in patients with glomus tu­
mors. So far, no mutations have been detected.
Previously, linkage calculations have provided evi­
dence for genomic imprinting of the distally located gene 
(Heutink et al. 1992). The same gene probably underlies 
the disorder in our present Family 2, where the pattern of 
inheritance is consistent with genomic imprinting. In 
Family 1, all 30 patients have inherited the trait from their 
father, whereas the obligate earner C-Vl.2 (Fig,2C), who 
has a maternally inherited genetic defect, has no clinical 
signs at the age of 65. Apparently, the proximal gene is 
also subject to genomic imprinting.
What is the role of genomic imprinting in tumor devel­
opment and how does it relate to the increased risk for tu­
mors in the offspring of male carriers? Patients often de­
velop more than one tumor affecting different glomus 
bodies. These tumors apparently originate from different 
paraganglionic cells, suggesting that one or both of the 
predisposing genes on l lq  code for tumor-suppressor pro­
teins. Assuming that both genes code for functionally 
equivalent tumor suppressors, the Knudson hypothesis 
(Knudson 1986) would predict that both copies of the two 
genes have to be turned off before glomus tumors can de­
velop (Fig. 5). In this respect, genomic imprinting would 
account for the silencing of the two maternal copies,
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Fig.SÀ, B A model for the ini­
tiation of glomus tumor devel­
opment. The maternal {MAT) 
and paternal (PAT) chromo­
somes 11 are shown with all 
four copies of the two glomus 
tumor suppressing genes being 
represented by horizontal boxes. 
A In the normal situation, the 
maternal gene copies are in­
active because of genomic im­
printing (cross-hatched boxes), 
whereas the paternal copies pro­
duce a growth suppressing pro­
tein (S). The same is true in the 
case of a maternally inherited 
mutation in one of the genes.
B When a mutation is inherited 
paternally, only one gene copy 
produces the suppressor protein. 
As soon as a somatic mutation 
turns off the remaining copy, 
the cell is released from growth 
suppression and will start to 
divide. Upon loss of imprinting 
of one or both of the maternal 
gene copies, tumor progression 
would require their transcrip­
tional inactivation by mutation 
or deletion
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whereas a paternally inherited mutation in one of the 
genes would represent the third hit. A single somatic mu­
tation in the remaining active paternal copy would subse­
quently suffice to initiate tumor growth (Fig.SB). Mater­
nally inherited mutations would not (or only very rarely) 
give rise to tumor development because it would require 
the inactivation of the two paternally transcribed gene 
copies in a single cell (Fig. 5A). Recently, allelic imbal­
ance was observed in glomus tumors for markers on l lq  
with (partial) loss of maternal alleles (Devilee et al. 1994). 
This phenomenon can be neatly explained by our model, 
assuming that, as observed for imprinted genes in other 
tumors (Ogawa et al. 1993; Rainier et al. 1993; Gurp et al. 
1994), the imprinted copies of the glomus tumor genes 
can become transcriptionally active. In this case, tumor 
progression would require additional hits, e.g., the so­
matic loss of the maternal chromosome (Fig.SB). Al­
though the proposed model, based on imprinting, is able 
to account for the relative risk for tumor development in 
disease gene carriers, and for the molecular events ob­
served in tumor cells, stronger evidence has to await the 
isolation of both glomus tumor genes and the elucidation 
of their transcriptional regulation.
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